Dxcover Limited: May is Brain Cancer Awareness Month
Timely Focus on Brain Cancer Early Detection Dxcover Limited, a clinical-stage diagnostics company pioneering its multi-omic spectral analysis (MOSA) for early detection of solid tumor cancers is
Stay updated with breaking news from Matthewj Baker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Timely Focus on Brain Cancer Early Detection Dxcover Limited, a clinical-stage diagnostics company pioneering its multi-omic spectral analysis (MOSA) for early detection of solid tumor cancers is
Dxcover Limited, a clinical-stage diagnostics company pioneering multi-omic spectral analysis (MOSA) for early detection of multiple cancers, will present an abstract on its CREATE-2 Colorectal Cancer & Adenoma Test Evaluation of a Multi-Omic Blood...
Clinical-stage diagnostics spin-out Dxcover has raised almost £10 million for its novel technology for early detection of multiple cancers, founded on research carried out at the University of Strathclyde. Click to read more...
Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the upcoming presentation of new data
Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology